Βασίλης Κόκκας

Εργαστήριο Φαρμακολογίας, Ιατρικό Τμήμα Αριστοτελείου Πανεπιστημίου, Θεσσαλονίκη, Ελλάς

Basilis Kokkas

Department of Pharmacology, Medical School, Aristotle University of Thessaloniki, Greece

2. Varmus H.: Oncogenes and transcriptional control. Sci­ence 238: 1337-1339 (1987)

3. Guyton A., Hall J.: Text book of Medical Physiology. W.B. Saunders Company, Philadelphia, 1996

4. Watson J.: Structure and behavior of genes and chromo­somes. In: (Gelehrter T., Collins F., eds) Principles of Medi­cal Genetics. Pp. 9-25, Williams and Wilkins, Baltimore, 1990

5. Darnell J., Lodish H., Baltomore D.: Molecular Cell Biol­ogy. Scientific American Books, New York, 1990

6. Holum J.: Fundamentals of General, Organic and Biologi­cal Chemistry. J. Wisley and Sons Inc., New York, 1994

7. Murray R.: Cancer, oncogenes and growth factors. In: (Murray R., Granner D., Mayes P., Rodwell V., eds) Harper’s Biochemistry. P. 650, Prentice-Hall Intern. Inc., London, 1990

8. Boveri Th.: Cancer genetics. In: (Gelehrter T., Collins F., eds) Principles of Medical Genetics. P. 239, Williams and Wilkins, Baltimore, 1990

9. Davis S., Granner D.: Insulin, oral hypoglycemic agents and the pharmacology of endocrine pancreas. In: (Hardman J. et al. eds) Goodman and Gilman’s. The Pharmacological Basis of Therapeutics. Pp. 1487-1517, McGraw – Hill, New York, 1996

10. Srivastava A.: Use of pharmacological agents in eluci­dating the mechanism of insulin action. Trends Pharmacol. Sci. 19: 205-208 (1998)

11. Augustin H.: Antiangiogenic tumour therapy will it work? Trends Pharmacol. Sci. 19: 216-224 (1998)

12. Ross E.: Pharmacodynamics. In: (Hardman J. et al. eds) Goodman and Gilman’s. The Pharmacological Basis of Therapeutics. Pp. 29-41, McGraw – Hill, New York, 1996

13. Wiegers G., Reul M.: Induction of cytokine receptors by glucorticoids. Trends Pharmacol. Sci. 19: 317-321 (1998)

14. Κόκκας Β.: Φάρμακα σε χρόνιες φλεγμονές. Επιθ. Κλιν. Φαρμακολ. Φαρμακοκιν. 15: 91-100 (1997)

15. Roit I.: Essential Immunology. Blackwell Sci. Publ. Lon­don, 1991

16. Lunes E., Hammond E., VarGam A.: Cytokines as mes­sengers of neuroimmyne interactions. Trends Neuro­sci. 19: 46-47 (1996)

17. Leroith D., Rogers C.: Growth factors and cytokines. In: (Becker K., ed.) Principles and Practice of Endocrinol­ogy and Metabolism. P. 1451, Lippincott J. Co. Philadel­phia, 1995

18. Benzamini E., Sunshine G., Leskowitz S.: Immunology. A short course. Willey-Liss, New York, 1996

19. Godfraind T. (ed.): The IUPHAR Compendium of Recep­tor Characterization and Classification. IUPHAR Media, Lon­don, 1998

20. Wells T., Power C., Proudfoot A.: Definition, function and pathophysiological significance of chemokine receptor. Trends Pharmacol. Sci. 19: 376-379 (1998)

21. Barbuto J., Hersh E., Salmon S.: Immunopharmacol­ogy. In: (Katzung B., ed.) Basic and Clinical Pharmacol­ogy. Pp. 858-878, Prentice-Hall Intern. Inc. Con. USA, 1995

22. Diasio R., LoBuglio A.: Immunomodulators. In: (Hardman J. et al., eds) Goodman and Gilman’s. The Pharmacological basis of Therapeutics. Pp. 1291-1308, McGraw – Hill, New York, 1996

23. Wilson J.: Androgens. In: (Hardman J. et al., eds) Goodman and Gilman’s. The Pharmacological basis of Therapeutics. Pp. 1441-1457, McGraw – Hill, New York, 1996

24. Κόκκας Β.: Κατάχρηση φαρμάκων από τους αθλητές. Ιατρολογοτεχνική Στέγη No 65: 29-33 (1985)

25. Chambers H., Sande M.: Antimicrobial agents. The ami­noglycosides. In: (Hardman J. et al., eds) Goodman and Gilman’s. The Pharmacological basis of Therapeutics. Pp. 1103-1121, McGraw – Hill, New York, 1996

26. Παραδέλλης Α.: Κλινική Φαρμακολογία. University Studio Press, Θεσσαλονίκη, 1992

27. Pipsky J.: The glimmer of HIV proteinase inhibitors. Lan­cet 345: 936-937 (1995)

28. Κόκκας Β.: Φάρμακα ενάντια στον HIV- ρετροϊό. Τάσεις και προβληματισμοί. Ελλην. Αρχεία AIDS. 4: 318-323 (1996)

29. Salmon S., Santorelli A.: Cancer chemotherapy. In: (Katzung B., ed.) Basic and Clinical Pharmacology. Pp. 823-857, Prentice-Hall Intern. Inc. Con. USA, 1995

30. Papakonstantinou E., Karakioulakis G., Kokkas B., Pa­padopoulos C.L., Roth M: Angiotensin II induced glycosami­noglycan synthesis by primary human vascular smooth muscle cells is mediated by subtype-1 angiotensin II recep­tors. In: 2 Eur. Congress of Pharmacology, Budapest Hun­gary, 3-7 July 1999 (Abstract)

31. Jackson E., Garrison J.: Renin and angiotensin. In: (Hardman J. et al., eds) Goodman and Gilman’s. The Phar­macological basis of Therapeutics. Pp. 733-758, McGraw – Hill, New York, 1996

32. Sagot Y., Vejsada R., Kato A.: Clinical and molecular aspects of motoneurone diseases. Trends Pharmacol. Sci. 18: 330-336 (1997)

33. Anglada M., Felipe A., Cascado J.: Transport and mode of action of nucleoside derivatives used in chemical and an­tiviral therapies. Trends Pharmacol. Sci. 19: 424-429 (1998)

34. Backelandt M.: A new reverser of drug resistance. Pro­ceedings of the symposium From the molecular biology to the bedside oncology, Thessaloniki 4-6 June 1998